Last 12 months
Inside the activity.
15 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 7 | 0 |
| May 2026 | 4 | 0 |
| Jun 2026 | 1 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2021 Filed Jun 8, 2021 20:00 UTC |
Tenwick David ADirector
|
PurchaseCommon Stock | 10,000 | $15.00 | $150,000.00 |
DisclosureSEC source: 0001209191-21-038862 · doc4.xml · nonDerivative · entry 1 Tenwick David A · CIK 0001382750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,985 F1 · balance_after: *Reflects the one-for-twelve reverse stock split that became effective on December 31, 2018. Read SEC document |
| June 04, 2021 Filed Jun 9, 2021 20:07 UTC Amendment |
Tenwick David ADirector
|
SaleCommon Stock | 10,000 | $15.00 | $150,000.00 |
DisclosureSEC source: 0001209191-21-039164 · doc4a.xml · nonDerivative · entry 1 Tenwick David A · CIK 0001382750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,985 F1 · kind: This filing is to amend Form 4 filed with the SEC on 2021-06-08 at 16:00:15. SEC Accession No. 0001209191-21-038862. Box 3, code "P" was used in error. F2 · balance_after: *Reflects the one-for-twelve reverse stock split that became effective on December 31, 2018. Read SEC document |
| January 11, 2019 Filed Jan 12, 2019 00:06 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 1,045 | $3.75 | $3,918.75 |
DisclosureSEC source: 0001402258-19-000009 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 394,982 F1 · ownership.direct: Charles Frischer owns 370,859 shares directly, 13,123 are held in his IRA and 11,000 shares are held by the Libby Frischer Family Partnership, L.P., of which, he is the sole General Partner. Read SEC document |
| January 07, 2019 Filed Jan 7, 2019 22:45 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 1,076 | $3.15 | $3,389.40 |
DisclosureSEC source: 0001402258-19-000006 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 387,623 F1 · ownership.direct: Charles Frischer owns 363,500 shares directly, 13,123 shares are held in his IRA and 11,000 shares are held by the Libby Frischer Family Partnership, L.P., of which, Charles Frischer is the sole General Partner. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 02:11 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 4,854 | $2.68 | $13,008.72 |
DisclosureSEC source: 0001402258-19-000002 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 386,547 F1 · ownership.direct: Charles Frischer owns 362,424 shares directly, 13,123 shares are held in his IRA and 11,000 shares are held by the Libby Frischer Family Partnership, L.P., of which, Charles Frischer is the sole General Partner. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 00:16 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 5,092 | $2.25 | $11,457.00 |
DisclosureSEC source: 0001402258-19-000001 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 381,693 F1 · ownership.direct: Charles Frischer owns 357,570 shares directly, 13,123 shares are held in his IRA and 11,000 shares are held by the Libby Frischer Family Partnership, L.P., of which, Charles Frischer is the sole General Partner. Read SEC document |
| December 27, 2018 Filed Dec 28, 2018 23:07 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 18,077 | $1.44 | $26,030.88 |
DisclosureSEC source: 0001402258-18-000054 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 376,601 F1 · ownership.direct: Charles Frischer owns 352,478 shares directly, 13,123 shares are held in his IRA and 11,000 shares are held by the Libby Frischer Family Partnership, of which, Charles Frischer is the sole General Partner. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 18:29 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 16,159 | $2.20 | $35,549.80 |
DisclosureSEC source: 0001402258-18-000048 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 358,524 F1 · ownership.direct: Charles Frischer owns 334,401 shares directly, 13,123 shares are held in his IRA and 11,000 shares are owned by the Libby Frischer Family Partnership, L.P., of which, Charles Frischer is the sole General Partner. Read SEC document |
| November 29, 2018 Filed Nov 29, 2018 20:15 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001402258-18-000042 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 342,365 F1 · price: Charles Frischer owns 318,242 shares directly, 13,123 shares are held in his IRA and 11,000 shares are held by the Libby Frischer Family Partnership, L.P, of which, Charles Frischer is the sole General Partner. These 750 shares were acquired via inheritance. F1 · ownership.direct: Charles Frischer owns 318,242 shares directly, 13,123 shares are held in his IRA and 11,000 shares are held by the Libby Frischer Family Partnership, L.P, of which, Charles Frischer is the sole General Partner. These 750 shares were acquired via inheritance. Read SEC document |
| November 08, 2018 Filed Nov 10, 2018 00:57 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 4,182 | $2.22 | $9,284.04 |
DisclosureSEC source: 0001402258-18-000034 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 341,615 F1 · ownership.direct: Charles Frischer owns 318,242 directly, 12,373 shares in held in his IRA and 11,000 shares are owned by the Libby Frischer Family Partnership, LP, of which, Charles Frischer is the sole General Partner. Read SEC document |
| October 24, 2018 Filed Oct 25, 2018 18:19 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 6,501 | $2.24 | $14,562.24 |
DisclosureSEC source: 0001402258-18-000029 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 337,433 F1 · ownership.direct: Charles Frischer owns 314,060 shares directly, 12,373 shares are held in his IRA and 11,000 shares are held by the Libby Frischer Family Partnership, of which, Charles Frischer is the sole General Partner. Read SEC document |
| October 18, 2018 Filed Oct 22, 2018 12:30 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 8,958 | $2.28 | $20,424.24 |
DisclosureSEC source: 0001402258-18-000028 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 330,932 F1 · ownership.direct: Charles Frischer owns 307,559 shares directly, 12,373 shares are held in his IRA and 11,000 shares are held by the Libby Frischer Family Partnership, of which Charles Frischer is the sole General Partner. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:05 UTC |
Tenwick David ADirector
|
GrantCommon Stock | 125,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-026193 · doc4.xml · nonDerivative · entry 1 Tenwick David A · CIK 0001382750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 623,816 F1 · shares: Restricted stock granted pursuant to the Regional Health Properties, Inc.'s 2011 Stock Incentive Plan and in respect of 2018 compensation. F2 · shares: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 41,722 shares on January 1, 2019; (2) 41,722 shares of January 1, 2020; and (3) 41,722 shares on January 1, 2021. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:03 UTC |
Taylor Kenneth WayneDirector
|
GrantCommon Stock | 114,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-026192 · doc4.xml · nonDerivative · entry 1 Taylor Kenneth Wayne · CIK 0001731952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,736 F1 · shares: Restricted stock granted pursuant to the Regional Health Properties, Inc.'s 2011 Stock Incentive Plan and in respect of 2018 compensation. F2 · shares: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 38,246 shares on January 1, 2019; (2) 38,245 shares of January 1, 2020; and (3) 38,245 shares on January 1, 2021. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 20:01 UTC |
Morrison BrentDirector · Interim CEO
|
GrantCommon Stock | 125,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-026190 · doc4.xml · nonDerivative · entry 1 Morrison Brent · CIK 0001623063 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,908 F1 · shares: Restricted stock granted pursuant to the Regional Health Properties, Inc.'s 2011 Stock Incentive Plan and in respect of 2018 compensation. F2 · shares: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 41,722 shares on January 1, 2019; (2) 41,722 shares of January 1, 2020; and (3) 41,722 shares on January 1, 2021. Read SEC document |
| April 24, 2018 Filed Apr 26, 2018 13:14 UTC |
Fox Michael JDirector
Park City Capital, LLCDirector
|
GrantCommon Stock | 125,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-022525 · tv492095_4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,908 F1 · shares: Restricted stock granted pursuant to the 2011 Stock Incentive Plan and in respect of 2018 compensation. F2 · shares: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 41,722 shares on January 1, 2019; (2) 41,722 shares on January 1, 2020; and (3) 41,722 shares on January 1, 2021. Read SEC document |
| January 10, 2018 Filed Jan 10, 2019 21:32 UTC |
Frischer Charles L10% owner
|
PurchaseRegional Health Properties, Inc. Series A Preferred | 6,314 | $3.68 | $23,235.52 |
DisclosureSEC source: 0001402258-19-000008 · primary_doc.xml · nonDerivative · entry 1 Frischer Charles L · CIK 0001402258 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Please see footnote 1 Disclosed balance after: 393,937 F1 · ownership.direct: Charles Frischer owns 369,814 shares directly, 13,123 shares are held in his IRA and 11,000 shares are held by the Libby Frischer Family Partnership, L.P, of which, Charles Frischer is the sole General Partner. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:13 UTC |
SZAMES BRIAN MDirector
|
GrantCommon Stock | 23,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001004724-17-000028 · wf-form4_149384240489509.xml · nonDerivative · entry 1 SZAMES BRIAN M · CIK 0001074506 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,364 F1 · shares: 1. Restricted stock granted under AdCare Health Systems, Inc. 2011 Stock Incentive Plan and will vest on the following schedule: (i) 7,788 shares on January 1, 2018, (ii) 7,788 shares on January 1, 2019, and (iii) 7,788 shares on January 1, 2020. Read SEC document |
| January 09, 2017 Filed Mar 23, 2017 12:08 UTC |
Fox Michael JDirector
Park City Capital, LLCDirector
|
Other10% Convertible Subordinated Notes Due April 30, 2017 · Derivative | Not disclosed | Not disclosed | $1,000,000.00 |
DisclosureSEC source: 0001144204-17-016158 · v462510_4.xml · derivative · entry 1 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Park City Capital, LLC Disclosed balance after: 0 Underlying: Common Stock · 235,294 shares Expires 2017-04-30 F1 · derivative.exercise_price: On January 9, 2017, the Company's cash tender offer for its outstanding 10% Convertible Subordinated Notes Due April 30, 2017 (the "Convertible Notes") at a purchase price equal to $1,000 per $1,000 principal amount of Convertible Notes purchased, plus accrued and unpaid interest on such Convertible Notes up to, but not including, the payment date, expired. The Company accepted for payment all of the Convertible Notes validly tendered. The Reporting Persons tendered all of their Convertible Notes held by Park City Capital Offshore Master, Ltd., the principal amount of which was convertible (at a conversion price equal to $4.25 per share) into 235,294 shares of the Company's common stock, to the Company. F1 · kind: On January 9, 2017, the Company's cash tender offer for its outstanding 10% Convertible Subordinated Notes Due April 30, 2017 (the "Convertible Notes") at a purchase price equal to $1,000 per $1,000 principal amount of Convertible Notes purchased, plus accrued and unpaid interest on such Convertible Notes up to, but not including, the payment date, expired. The Company accepted for payment all of the Convertible Notes validly tendered. The Reporting Persons tendered all of their Convertible Notes held by Park City Capital Offshore Master, Ltd., the principal amount of which was convertible (at a conversion price equal to $4.25 per share) into 235,294 shares of the Company's common stock, to the Company. F1 · price: On January 9, 2017, the Company's cash tender offer for its outstanding 10% Convertible Subordinated Notes Due April 30, 2017 (the "Convertible Notes") at a purchase price equal to $1,000 per $1,000 principal amount of Convertible Notes purchased, plus accrued and unpaid interest on such Convertible Notes up to, but not including, the payment date, expired. The Company accepted for payment all of the Convertible Notes validly tendered. The Reporting Persons tendered all of their Convertible Notes held by Park City Capital Offshore Master, Ltd., the principal amount of which was convertible (at a conversion price equal to $4.25 per share) into 235,294 shares of the Company's common stock, to the Company. F1 · derivative.underlying_shares: On January 9, 2017, the Company's cash tender offer for its outstanding 10% Convertible Subordinated Notes Due April 30, 2017 (the "Convertible Notes") at a purchase price equal to $1,000 per $1,000 principal amount of Convertible Notes purchased, plus accrued and unpaid interest on such Convertible Notes up to, but not including, the payment date, expired. The Company accepted for payment all of the Convertible Notes validly tendered. The Reporting Persons tendered all of their Convertible Notes held by Park City Capital Offshore Master, Ltd., the principal amount of which was convertible (at a conversion price equal to $4.25 per share) into 235,294 shares of the Company's common stock, to the Company. F2 · derivative.underlying_shares: As the managing member of Park City Capital, LLC, Mr. Fox may be deemed to have beneficial ownership of the securities held by Park City Capital Offshore Master, Ltd. and Park City Special Opportunity Fund, LP, with respect to which Park City Capital, LLC, the investment manager to the funds, may be deemed to have beneficial ownership. Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 00:42 UTC |
Fox Michael JDirector
Park City Capital, LLCDirector
|
GrantCommon Stock | 24,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-16-140359 · v455384_4.xml · nonDerivative · entry 1 Fox Michael J · CIK 0001589232 · Director Park City Capital, LLC · CIK 0001573572 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,742 F1 · shares: Restricted stock granted pursuant to the AdCare Health Systems, Inc.'s 2011 Stock Incentive Plan and in respect of 2017 compensation. F2 · shares: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 8,170 shares on January 1, 2018; (2) 8,170 shares of January 1, 2019; and (3) 8,170 shares on January 1, 2020. Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 21:15 UTC |
Tenwick David ADirector
|
GrantCommon Stock | 24,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001004724-16-000254 · wf-form4_148226848816593.xml · nonDerivative · entry 1 Tenwick David A · CIK 0001382750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,650 F1 · shares: Restricted stock granted pursuant to the AdCare Health Systems, Inc.'s 2011 Stock Incentive Plan and in respect of 2017 compensation. F2 · shares: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 8,170 shares on January 1, 2018; (2) 8,170 shares of January 1, 2019; and (3) 8,170 shares on January 1, 2020. Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 21:11 UTC |
Knaup Thomas WDirector
|
GrantCommon Stock | 34,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001004724-16-000253 · wf-form4_148226826602911.xml · nonDerivative · entry 1 Knaup Thomas W · CIK 0001656268 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,588 F1 · shares: Restricted stock granted pursuant to the AdCare Health Systems, Inc.'s 2011 Stock Incentive Plan and in respect of 2017 compensation. F2 · shares: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 11,574 shares on January 1, 2018; (2) 11,574 shares of January 1, 2019; and (3) 11,574 shares on January 1, 2020. Read SEC document |
| December 16, 2016 Filed Dec 20, 2016 21:10 UTC |
Morrison BrentDirector
|
GrantCommon Stock | 24,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001004724-16-000252 · wf-form4_148226819457755.xml · nonDerivative · entry 1 Morrison Brent · CIK 0001623063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,742 F1 · shares: Restricted stock granted pursuant to the AdCare Health Systems, Inc.'s 2011 Stock Incentive Plan and in respect of 2017 compensation. F2 · shares: The shares of restricted stock will vest over a three-year period on the following schedule: (1) 8,170 shares on January 1, 2018; (2) 8,170 shares of January 1, 2019; and (3) 8,170 shares on January 1, 2020. Read SEC document |
| December 01, 2016 Filed Dec 1, 2016 16:23 UTC |
MCBRIDE WILLIAM IIIDirector · Chairman & CEO
|
PurchaseCommon Stock | 5,000 | $1.60 | $8,000.00 |
DisclosureSEC source: 0001004724-16-000238 · wf-form4_148062740044909.xml · nonDerivative · entry 1 MCBRIDE WILLIAM III · CIK 0000938131 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,143 Read SEC document |
| November 30, 2016 Filed Nov 30, 2016 21:34 UTC |
Rimland Allan JPresident & CFO
|
PurchaseCommon Stock | 2,700 | $1.60 | $4,320.00 |
DisclosureSEC source: 0001004724-16-000236 · wf-form4_148054165521855.xml · nonDerivative · entry 2 Rimland Allan J · CIK 0001638329 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,855 Read SEC document |
| November 29, 2016 Filed Nov 30, 2016 21:34 UTC |
Rimland Allan JPresident & CFO
|
PurchaseCommon Stock | 8,000 | $1.63 | $13,040.00 |
DisclosureSEC source: 0001004724-16-000236 · wf-form4_148054165521855.xml · nonDerivative · entry 1 Rimland Allan J · CIK 0001638329 · President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,155 Read SEC document |
| November 28, 2016 Filed Nov 28, 2016 16:08 UTC |
MCBRIDE WILLIAM IIIDirector · Chairman & CEO
|
PurchaseCommon Stock | 2,000 | $1.61 | $3,220.00 |
DisclosureSEC source: 0001004724-16-000234 · wf-form4_148036727743337.xml · nonDerivative · entry 4 MCBRIDE WILLIAM III · CIK 0000938131 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,143 Read SEC document |
| November 28, 2016 Filed Nov 28, 2016 16:08 UTC |
MCBRIDE WILLIAM IIIDirector · Chairman & CEO
|
PurchaseCommon Stock | 4,000 | $1.60 | $6,400.00 |
DisclosureSEC source: 0001004724-16-000234 · wf-form4_148036727743337.xml · nonDerivative · entry 3 MCBRIDE WILLIAM III · CIK 0000938131 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,143 Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 16:08 UTC |
MCBRIDE WILLIAM IIIDirector · Chairman & CEO
|
PurchaseCommon Stock | 2,000 | $1.56 | $3,120.00 |
DisclosureSEC source: 0001004724-16-000234 · wf-form4_148036727743337.xml · nonDerivative · entry 2 MCBRIDE WILLIAM III · CIK 0000938131 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,143 Read SEC document |
| November 25, 2016 Filed Nov 28, 2016 16:08 UTC |
MCBRIDE WILLIAM IIIDirector · Chairman & CEO
|
PurchaseCommon Stock | 2,000 | $1.55 | $3,100.00 |
DisclosureSEC source: 0001004724-16-000234 · wf-form4_148036727743337.xml · nonDerivative · entry 1 MCBRIDE WILLIAM III · CIK 0000938131 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,143 Read SEC document |
| November 21, 2016 Filed Nov 22, 2016 11:45 UTC |
MCBRIDE WILLIAM IIIDirector · Chairman & CEO
|
PurchaseCommon Stock | 1,000 | $1.63 | $1,630.00 |
DisclosureSEC source: 0001004724-16-000232 · wf-form4_147983313792688.xml · nonDerivative · entry 3 MCBRIDE WILLIAM III · CIK 0000938131 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,143 Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 11:45 UTC |
MCBRIDE WILLIAM IIIDirector · Chairman & CEO
|
PurchaseCommon Stock | 1,500 | $1.60 | $2,400.00 |
DisclosureSEC source: 0001004724-16-000232 · wf-form4_147983313792688.xml · nonDerivative · entry 2 MCBRIDE WILLIAM III · CIK 0000938131 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,143 Read SEC document |
| November 18, 2016 Filed Nov 22, 2016 11:45 UTC |
MCBRIDE WILLIAM IIIDirector · Chairman & CEO
|
PurchaseCommon Stock | 7,500 | $1.61 | $12,075.00 |
DisclosureSEC source: 0001004724-16-000232 · wf-form4_147983313792688.xml · nonDerivative · entry 1 MCBRIDE WILLIAM III · CIK 0000938131 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,643 Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 20:04 UTC |
Tenwick David ADirector
|
Exercise / conversionCommon Stock Warrant (right to buy) · Derivative | 109,472 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001004724-16-000212 · wf-form4_147448823583950.xml · derivative · entry 3 Tenwick David A · CIK 0001382750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 109,472 shares Expires 2019-11-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 20:04 UTC |
Tenwick David ADirector
|
Tax withholdingCommon Stock | 50,214 | $2.27 | $113,835.14 |
DisclosureSEC source: 0001004724-16-000212 · wf-form4_147448823583950.xml · nonDerivative · entry 2 Tenwick David A · CIK 0001382750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,140 Read SEC document |
| September 19, 2016 Filed Sep 21, 2016 20:04 UTC |
Tenwick David ADirector
|
Exercise / conversionCommon Stock | 109,472 | $1.04 | $113,850.88 |
DisclosureSEC source: 0001004724-16-000212 · wf-form4_147448823583950.xml · nonDerivative · entry 1 Tenwick David A · CIK 0001382750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.